Jeremy N. Burrows

Liverpool School of Tropical Medicine — United Kingdom

Medicine · Health Sciences

46h-index9.5kcitations183works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(102), Computational Drug Discovery Methods(52), Mosquito-borne diseases and control(39), HIV/AIDS drug development and treatment(28), Research on Leishmaniasis Studies(23)

Publications182 total

Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV-2 Papain-like Protease (PL<sup>pro</sup>) Inhibitors
ACS Omega·2025· 2 citedOpen Access
Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance
Science Advances·2025Open Access
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites
Antimicrobial Agents and Chemotherapy·2025Open Access
In vivo screen of Plasmodium targets for mosquito-based malaria control
Nature·2025· 10 citedOpen Access
CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial
Communications Biology·2025· 1 citedOpen Access
<i>Anopheles</i> mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinone
Science Translational Medicine·2025· 9 citedOpen Access
Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance
2025· 1 citedOpen Access
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission
Science Advances·2024· 3 citedOpen Access
Tambjamines as Fast-Acting Multistage Antimalarials
ACS Infectious Diseases·2024· 5 citedOpen Access
Global Health Priority Box─Proactive Pandemic Preparedness
ACS Infectious Diseases·2024· 6 citedOpen Access
Author Correction: Antimalarial drug discovery: progress and approaches
Nature Reviews Drug Discovery·2024· 1 citedOpen Access
Discovery of 1,3,4-oxadiazoles with slow-action activity against Plasmodium falciparum malaria parasites
European Journal of Medicinal Chemistry·2024· 1 citedOpen Access
Optimization of diastereomeric dihydropyridines as antimalarials
European Journal of Medicinal Chemistry·2024
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
Journal of Cheminformatics·2024· 3 citedOpen Access
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Nature Reviews Drug Discovery·2024· 29 cited
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
2024Open Access
CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial
2024Open Access
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection
2024· 1 citedOpen Access
Oxidative stress changes the effectiveness of artemisinin in <i>Plasmodium falciparum</i>
mBio·2024· 14 citedOpen Access
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
Nature Communications·2024· 14 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Susan A. Charman(17), Karen L. White(13), Timothy N. C. Wells(11), David A. Fidock(9), Marı́a Belén Jiménez-Dı́az(9), Íñigo Angulo‐Barturen(9), Margaret A. Phillips(8), Sergio Wittlin(8), Santiago Ferrer(8), Didier Leroy(8), David M. Shackleford(8), Francisco‐Javier Gamo(8), David Waterson(8), John White(7), Farah El Mazouni(7), Xiaoyi Deng(7), Pradipsinh K. Rathod(7), Sreekanth Kokkonda(6), Maria Santos Martínez(6), Vicky M. Avery(6)